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Labile iron poolCellular iron metabolism is essentially controlled by the binding of cytosolic iron regulatory proteins (IRP1
or IRP2) to iron-responsive elements (IREs) located on mRNAs coding for proteins involved in iron
acquisition, utilization and storage. The 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is one of the most
potent toxins of current interest that occurs as poisonous chemical in the environment. TCDD exposure has
been reported to induce a broad spectrum of toxic and biological responses, including signiﬁcant changes
in gene expression for heme and iron metabolism associated with liver injury. Here, we have investigated
the molecular effects of TCDD on the iron metabolism providing the ﬁrst evidence that administration of
the toxin TCDD to mammalian cells affects the maintenance of iron homeostasis. We found that exposure
of Madin–Darby Bovine Kidney cell to TCDD caused a divergent modulation of IRP1 and IRP2 RNA-binding
capacity. Interestingly, we observed a concomitant IRP1 down-regulation and IRP2 up-regulation thus
determining a marked enhancement of transferrin receptor 1 (TfR-1) expression and a biphasic response
in ferritin content. The changed ferritin content coupled to TfR-1 induction after TCDD exposure impairs
the cellular iron homeostasis, ultimately leading to signiﬁcant changes in the labile iron pool (LIP) extent.
Since important iron requirement changes occur during the regulation of cell growth, it is not surprising
that the dioxin-dependent iron metabolism dysregulation herein described may be linked to cell-fate
decision, supporting the hypothesis of a central connection among exposure to dioxins and the regulation
of critical cellular processes.dioxin; IRPs, iron regulatory
in receptor 1; DMT-1, divalent
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Many proteins that carry out fundamental cellular processes,
including DNA synthesis and ATP production, require iron to function.
Consequently, cellular iron deﬁciency abrogates the activity of iron-
dependent proteins causing cellular growth arrest and death [1].
Conversely, iron excess is toxic because ferrous iron reacts with
hydrogen peroxides or lipid peroxides to generate hydroxyl or lipid
radicals, respectively. In turn, these radicals damage lipids membrane,proteins, and nucleic acids [2,3]. Thus, iron homeostasis must be tightly
controlled at both systemic and cellular levels. The peptide hormone
hepcidin is the master regulator of the systemic iron metabolism and is
predominantly expressed in the liver [4,5]. Hepcidin modulates iron
availability by promoting the internalization and degradation of the
cellular iron exporter ferroportin 1, thus controlling the use of iron in
organs. Cellular iron homeostasis is achieved by the coordinated
expression of proteins involved in iron uptake, export, storage, and
utilization [6]. The post-transcriptional control mediated by the iron
regulatory proteins (IRPs) has emerged as central and essential [7–10].
In fact, the binding of IRP1 or IRP2 to cis-acting mRNA motifs termed
iron-responsive elements (IREs) regulates the expression of proteins
involved in iron acquisition, such as transferrin receptor 1 (TfR-1) [11]
and divalent metal transporter 1 (DMT-1) [12] and storage, such as
ferritin [13]. In particular, the IRPs binding to IRE on respective mRNAs
represses ferritin protein synthesis and stabilizes the mRNAs of TfR-1
and DMT-1, promoting their translation. IRP1, the cytosolic counterpart
of mitochondrial aconitase [14], is a bifunctional protein that, through
[4Fe-4S] cluster assembly/disassembly, shifts from the aconitase to the
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the [4Fe-4S] cluster and its stability is controlled by an iron-regulated E3
ubiquitin ligase [15,16]. Consequently, the cytosolic free iron (labile
iron pool, LIP) regulates RNA-binding capacity of IRP1 or induces IRP2
degradation. The IRPs RNA-binding activity is also regulated by other
exogenous and endogenous factors, such as oxidative stress [17],
nitric oxide signaling [18], protein phosphorylation [19], hypoxia/
reoxygenation [20,21], viral infections [22], estrogens [23] as well as
oxalomalic acid, an inhibitor of IRP1/c-acon [24–26].
Most recently, mechanism by which xenobiotics such as polychlori-
nated dibenzo-p-dioxins (PCDDs) and by-products, exert their biolog-
ical and/or toxic effects have been the subject of intense investigations.
The 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is one of the most
potent toxins that occur as poisonous chemicals in the environment
[27]. In the last years, higher levels of TCDDwere detected in pasturage
areas and in milk samples from several farm animals collected in some
areas of Campania Region (South Italy) [28,29]. Dietary ingestion is
considered the primary source of general population exposure to
TCDD. A major cause of concern related to exposure to dioxin-like
compounds is their possible carcinogenicity in humans. Various
molecular mechanisms have been suggested to be active in tumor
induction by TCDD, and it is actually considered to act as a cancer
promoter [30,31]. Besides being carcinogenic, dioxins induce a broad
spectrum of toxic and biological responses in the reproductive and
immune systems, including interference with endocrine system func-
tions, immune suppression, teratogenicity, and hepatotoxicity [32–34].
Most of the biological effects of dioxins are linked to the aryl
hydrocarbon receptor (AhR) activation [35,36]. The AhR is a key
member of a transcription factor superfamily involved in the altered
expression of target genes that results from exposure to dioxins.
Recently, it has been reported that AhR functions as a ligand-dependent
E3 ubiquitin ligase of certain nuclear receptors [37], such as the estrogen
and androgen receptors. Besides the response to chemicals and
pollutants, experimental evidencedemonstrates thatAhRalsopossesses
physiological functions in crosstalk with other transcription factors that
are independent of exogenous chemical exposure [38]. The binding of
TCDD to the AhR and subsequent changes in gene expression have been
studied intensively, but themechanisms by which these lead to toxicity
are still unclear. Interestingly, TCDD has been shown to interfere with
the homeostasis of some cations and oligoelements, as well as iron
metabolism [39,40]. In fact, it was demonstrated that iron potentiates
both thehepatic porphyria and toxicityof TCDD in susceptiblemice in an
oxidative process with disturbance of iron regulatory protein activity
[41]. Moreover, signiﬁcant changes in genes expression for heme
metabolism and iron homeostasis associated with liver injury were
found in mice exposed for either 2 or 5 weeks to TCDD [42].
However, to our knowledge, no study has hitherto examined
thoroughly the inﬂuence of TCDD in the maintenance of iron
homeostasis. Hence, within a research project aimed to investigate
the dioxin effects on cattle, we have evaluated the molecular effects of
TCDD on the ironmetabolism using an epithelial-like cell line, Madin–
Darby Bovine Kidney (MDBK), a useful and standardized in vitro
model for studying TCDD exposure in mammalian cells [43–45]. In
particular, we have focused on the possible impact of this dioxin
isomer in the expression and activity of the main cellular proteins
involved in iron metabolism.2. Materials and methods
2.1. Cell cultures and TCDD treatment
Madin–Darby Bovine Kidney (MDBK) cells (CCL22, American Type
Culture Collection) were cultured in Dulbecco's modiﬁed Eagle's
minimal essential medium (DMEM), supplemented with 2% fetal calf
serum, 1% L-glutamine, 1% penicillin/streptomycin, 0.2% sodiumpyruvate and 0.1% tylosin. All cultures were maintained in an
incubator at 37 °C (in 5% CO2/95% air).
Conﬂuent cultures were exposed to different concentrations of
TCDD (0.01, 1, 100 pg/ml) for 1, 12, 24, 48, 72 h. For iron repletion–
depletion experiments, cells were treated with 50 μg/ml ferric
ammonium citrate (FAC) or with 100 μM desferrioxamine (DFO)
(Desferal, Novartis, Origgio, Varese, Italy) in growth medium for 18 h.
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) in toluene was pur-
chased from Supelco (St. Louis, MO). The original TCDD concentration
was 10 μg/ml, and it was initially diluted to give a 10,000 pg/ml stock
solution by mixing with DMEM. This stock solution was then diluted
to give working solutions of 0.01, 1 and 100 pg/ml in DMEM, which
were added to cultures. All other chemicals were of the highest purity
that is commercially available.
2.2. Cell viability and proliferation
Cell viability was evaluated by MTT assay. The principle of this
method is that 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2 H-tetra-
zolium bromide (MTT), a soluble tetrazolium salt, is converted to
insoluble formazan by active mitochondrial dehydrogenases of living
cells. Such conversion from yellowish soluble tetrazolium to purple
formazan can be assayed spectroﬂuorimetrically. MDBK cells (2×104
cells/well), in 96-well plates, at conﬂuency, were exposed to TCDD
(0.01, 1, or 100 pg/ml) and incubated for 12, 24 and 48 h. MTT
(5 mg/ml) was added to cells and after further 4 h of incubation,
the medium was removed and replaced with DMSO to solubilize
the MTT formazan crystals. The spectrophotometer absorbance at
570 nm was determined. Data are calculated as a percentage of
the control, and results are the mean±SEM of four independent
experiments performed in duplicate.
To evaluate cell proliferation, MDBK cells (30×104 cells/ﬂask) were
plated in 25 cm2 ﬂask and, after reaching the conﬂuence, were exposed
to TCDD (0.01, 1, and 100 pg/ml) and incubated for 12, 24, or 48 h. At
different times of incubation, adherent cells, removed from the culture
substrate by treatment with trypsin–EDTA solution, were mixed with
cells previously collected by centrifugation in supernatant from the
same ﬂask and resuspended at an adequate concentration in PBS. Thus,
the entire cell population of the culture was reconstituted for deter-
mination of the cell number by counting them in a Burker chamber.
Data are expressed as a percentage of the control, and results are the
mean±SEM of four independent experiments performed in duplicate.
2.3. Preparation of cellular extracts
After different times of incubation with TCDD, MDBK cells were
washed and scraped off with PBS containing 1 mM EDTA. To obtain
cytosolic extracts for electrophoretic mobility shift assay (EMSA), cells
were treated with lysis buffer containing 10 mMHEPES, pH 7.5, 3 mM
MgCl2, 40 mM KCl, 5% (v/v) glycerol, 1 mM dithiothreitol (DTT), 0.2%
(v/v) Nonidet P-40 (NP-40) and protease inhibitor tablets (Roche,
Mannheim, Germany) at 4 °C. Cell debris and nuclei were pelleted by
centrifugation at 15,000 ×g for 10 min at 4 °C, and supernatants were
stored at −80 °C. For Western blot analysis, cells were collected by
scraping and low-speed centrifugation. Cell pellets were lysed at 4 °C
for 30 min in a buffer containing 20 mM Tris–HCl, pH 7.4, 150 mM
NaCl, 5 mM EDTA, 5% (v/v) glycerol, 10 mM NP-40 and protease
inhibitor tablets (Roche). The supernatant fraction was obtained by
centrifugation at 15,000 ×g for 10 min at 4 °C and then stored at
−80 °C. Protein concentrationwas determined by the Bio-Rad protein
assay (Bio-Rad, Milan, Italy).
2.4. Electrophoretic mobility-shift assay (EMSA)
Plasmid pSPT-fer containing the sequence corresponding to the IRE
of the H-chain of human ferritin, linearized at the BamHI site, was
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shift analysis, cytosolic extracts (5 μg) were incubated for 30 min at
room temperature with 0.2 ng of in vitro transcribed 32P-labelled IRE
RNA. The reaction was performed in buffer containing 10 mM HEPES,
pH 7.5, 3 mM MgCl2, 40 mM KCl, 5% (v/v) glycerol, 1 mM DTT and
0.07% (v/v) NP-40, in a ﬁnal volume of 20 μl. To recover total IRP1
binding activity, cytosolic extracts were pre-incubated for 10 min with
2-mercaptoethanol (2-ME) at 2% (v/v) ﬁnal concentration, before the
addition of 32P-labelled IRE RNA. Unbound RNAwas digested for 10 min
with 1 U RNase T1 (Roche), and non-speciﬁc RNA–protein interactions
were displaced by the addition of 5 mg/ml heparin for 10 min. RNA–
protein complexes were separated on 6% non-denaturing polyacryl-
amide gel for 2 h at 200 V. After electrophoresis, the gel was dried and
autoradiographed at−80 °C. The IRPs–IRE complexes were quantiﬁed
with a GS-800 imaging densitometer (Bio-Rad). Concerning IRP1, the
results are expressed as the percentage of RNA-binding activity versus
2-mercaptoethanol treated samples; about IRP2 binding activity, results
are expressed as percentage of untreated cells.
2.5. Western blot analysis
Samples containing 50–100 μg of proteins were denatured, separat-
ed on a 12% (for ferritin) or 8% (for IRP1, IRP2, TfR-1 and DMT-1) SDS-
polyacrylamide gel and electro-transferred onto a nitrocellulose
membrane (Amersham Biosciences, Little Chalfont, Buckinghamshire,
UK) using a Bio-Rad Transblot (Bio-Rad). Proteins were visualized on
the ﬁlters by reversible staining with Ponceau-S solution and destained
in PBS. Membranes were blocked at room temperature in milk buffer
[1× PBS, 5-10% (w/v) non-fat dry milk, 0.2% (v/v) Tween-20] and then
incubated at 4 °C overnight with 1:1000 rabbit polyclonal antibody to
human ferritin (Dako Cytomation, Glostrup, Denmark), or with 1:1000
mouse monoclonal antibody to human transferrin receptor 1 (Zymed
Laboratories Inc., CA), or with 1:250 goat polyclonal antibody to human
IRP1 (Santa Cruz Biotechnology, Santa Cruz, CA), or with 1:250 goat
polyclonal antibody to human IRP2 (Santa Cruz Biotechnology), or with
1:250 goat polyclonal antibody to human DMT-1 (Santa Cruz
Biotechnology). Subsequently, the membranes were incubated for
90 min at room temperature with peroxidase-conjugated goat anti-
rabbit IgG, or peroxidase-conjugated goat anti-mouse IgG+IgM, or
peroxidase-conjugated rabbit anti-goat IgG (all the secondary anti-
bodies were purchased from Jackson ImmunoResearch Laboratories,
Baltimore Pike, West Grove, PA). The resulting complexes were
visualized using chemiluminescence Western blotting detection
reagents (ECL, Amersham Biosciences). The optical density of the
bands was determined by a GS-800 imaging densitometer (Bio-Rad).
Normalization of results was ensured by incubating the nitrocellulose
membranes in parallel with the β-actin antibody.
2.6. RNA extraction, Northern blot and RT-PCR analyses
Total RNA was isolated from cells using TRIzol reagent (Invitrogen
Life Technologies, Carlsbad, CA) as indicated in the manufacturer's
instructions. The levels of TfR mRNA were evaluated by using PCR
ampliﬁcation of reverse-transcribed mRNA. Total RNA was reverse-
transcribed into cDNA by using the random priming method and M-
MLV-Reverse Transcriptase (Invitrogen). cDNA was ampliﬁed by PCR
using Taq-Polymerase (Invitrogen) according to the manufacturer's
instructions. The primers for TfR were 5′-CAGCCCAGCAGAAGCAT-
TATC-3′ (forward) and GGAAGTAGCACGGAAGAAGTC-3′ (reverse);
the primers for GADPH (house-keeping gene) were 5′-ACATCAA-
GAAGGTGGTGAAG-3′ (forward) and 5′-CTCTTGTGCTCTTGCTGG-3′
(reverse). The TfR and GADPH cDNA were co-ampliﬁed under the
following conditions: a ﬁrst cycle of denaturation at 94 °C for 2 min,
then 35 cycles of denaturation at 94 °C for 30 s, annealing at 46 °C for
45 s, extension at 72 °C for 1 min and one additional cycle of extension
at 72 °C for 8 min. The PCR products were run on 1% agarose gel andstained with ethidium bromide. The intensities of the bands were
quantiﬁed and values normalized to GADPH levels.
For Northern blots analysis, 15 μg of total RNA was fractionated on
a 1.5% agarose denaturing formaldehyde gel and then transferred to
Hybond-N+ ﬁlter (Amersham Biosciences). The hybridization was
performed for 18 h at 65 °C in 0.5 M sodium phosphate buffer, pH 7.2,
1 mM EDTA, pH 8.0, 7% (w/v) SDS. The ﬁlters were washed in 50 mM
sodium phosphate buffer, pH 7.2, 1% (w/v) SDS at 65 °C, and then
autoradiographed at −80 °C with an intensifying screen. A cDNA
fragment corresponding to human H-ferritin, was 32P-radiolabeled
using the random priming method (Amersham Biosciences).
2.7. Cellular labile iron pool (LIP) evaluation
The cellular labile iron contentwas estimated by a ﬂuorimetric assay
using the metal-sensitive probe calcein (CA) [47] and the strong
membrane-permeant iron chelator SIH (salicylaldehyde isonicotinoyl
hydrazone), generously provided by Prof. Prem Ponka (McGill Univer-
sity, Montreal, QC, Canada). After incubation for 12, 24 and 48 h with
0.01, 1, or 100 pg/ml of TCDD,MDBK cells, plated at a density of 1.5×103
cells/well, were loaded with 0.5 μM CA-AM (calcein-acetomethoxy,
Molecular Probes, Invitrogen, Eugene, OR) for 45 min at 37 °C in
calcium- and bicarbonate-free modiﬁed Krebs Henseleit buffer (KHB),
consisting of 20 mMHEPES, pH7.4, 119 mMNaCl, 4.9 mMKCl, 0.96 mM
KH2PO4 and 5 mMglucose. CA-AM rapidly penetrates across the plasma
membrane and is intracellularly hydrolysed to release free CA. After
loading, the cultureswerewashedof excessCA-AMtwotimeswithKHB.
Cellular CA ﬂuorescence was recorded in a Perkin Elmer microplate
reader (Perkin Elmer LS 55 Luminescence Spectrometer, Beaconsﬁeld,
UK) using a ﬁlter combinationwith an excitationwavelength of 485 nm
and an emission wavelength of 530 nm (slits 5 nm). Cell cultures
without CA-AM were used as blank to correct non-speciﬁc autoﬂuo-
rescence. Trypan blue was added in all experiments to eliminate extra-
cellular ﬂuorescence. Once hydrolyzed, calcein becomes trapped in the
cytoplasm and emits intense green ﬂuorescence. The calcein-loaded
cells have a ﬂuorescence component (ΔF) that is quenched by
intracellular iron and can be revealed by addition of 100 μM SIH. The
rise in ﬂuorescence is equivalent to the change in calcein concentration
or to the amount of cellular iron originally bound to CA. Thus, the
changes in CA ﬂuorescence intensity were directly proportional to the
iron labile pool. To characterize the responsiveness of CA ﬂuorescence
toward different concentrations of intracellular iron, cells were
preloaded with ferrous ammonium sulphate, ferric ammonium citrate
or with the cell-permeable ferrous iron chelator SIH.
2.8. Statistical analysis
For the MTT assay, cell counting and LIP determination, results are
expressed asmean of percentage±standard error of themean (SEM) of
n observations respect to control cells (100%), where n represents the
number of experiments performed on different days. The results were
analyzed by one-way ANOVA followed by a Bonferroni post hoc test for
multiple comparisons. A p-value less than 0.05 was considered
signiﬁcant. The densitometric data fromEMSAandWesternblot analysis
are reported as percentage of controls±standard error of the mean
(SEM) of n observations, where n represents the number of experiments
performed on different days. Statistical signiﬁcance among the results
was determined by the ANOVA followed by the Newman–Keuls test.
A p-value less than 0.05 was considered statistically signiﬁcant.
3. Results
3.1. TCDD effect on MDBK cells viability and proliferation
We analyzed the effect of TCDD exposure on MDBK cells viability
and proliferation by measuring the mitochondrial redox capacity
Table 1







12 ½ 0.01 100±2.22a 111.57±4.36⁎, a1 101.96±2.04a 138±4.76⁎⁎⁎, a
100 109.26±1.28a 157±4.67⁎⁎⁎, a
24 ½ 0.01 104.84±1.6a 127±3.61⁎⁎, a1 103.8±1.9a 156.14±2.03⁎⁎⁎, a
100 122.4±0.95⁎⁎⁎, a 177.47±3.02⁎⁎⁎, a
48 ½ 0.01 105.4±1.45a 118.48±1.63⁎⁎, a1 113.3±2.43⁎, a 150.97±2.09⁎⁎⁎, a
100 145.6±2.38⁎⁎⁎, a 194.99±2.5⁎⁎⁎, a
Data are expressed as mean of percentage±SEM of four independent experiments
performed in duplicate vs. control cultures.
a n=32.
⁎ pb0.05 vs. control.
⁎⁎ pb0.01 vs. control.
⁎⁎⁎ pb0.001 vs. control.
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monolayers of MDBK cells were incubated in presence of 0.01, 1 and
100 pg/ml of TCDD and then theMTT assaywas performed at different
times (12, 24 and 48 h). As shown in Table 1, and reported previously
in another context [43], the exposure of MDBK cells to various amount
of TCDD caused a consistent increase in the mitochondrial dehydro-
genases reaching 145% with respect to control cells after 48 h of
incubation with 100 pg/ml of TCDD. Concomitantly, the number of
cells signiﬁcantly increased at all concentrations of TCDD (0.01, 1, and
100 pg/ml) and at all time intervals studied (12, 24 and 48 h). Hence,
the TCDD exposure determines an increase in cell proliferation and
viability at all concentration and times studied.Fig. 1. TCDD effect on iron regulatory proteins activity. (A) MDBK cells were treated with d
respectively). Proteins were extracted and subjected to electrophoretic mobility-shift assay
excess of 32P-labeled IRE probe in absence (top) or presence (bottom) of 2% 2-ME. RNA–prote
autoradiography. The autoradiograms shown are representative of four experiments. (B) IRP
experiments performed without 2-ME were plotted in graphs as percent of the control and a
line IRP-2). Graphs are distinctive depending by the indicated TCDD concentrations. ***pb03.2. TCDD modulates the iron regulatory proteins activity
In order to investigate the effects of TCDD exposure on cellular
iron metabolism, we ﬁrst analyzed the RNA-binding activity of IRPs.
To this aim, MDBK cells were exposed to different concentrations of
TCDD (0.01, 1 and 100 pg/ml) and then we examined at different
times of incubation (1, 12, 24, 48 and 72 h) the IRPs activity on cell
lysates by means of EMSA. The results revealed a divergent
regulation of IRPs activity, already evident at 24 h of TCDD exposure
and at the lowest dose (0.01 pg/ml) of the contaminant. Conversely,
brief incubation (1 h) of cells with TCDD did not change IRPs
binding capacity at all tested concentrations (data not shown). In
detail, as shown in Fig. 1, TCDD did cause a signiﬁcant time-
dependent decrease in IRP1 RNA-binding activity, reaching about
45% with respect to control after 48 h of incubation. Prolonged
treatment up to 72 h determined only very little changes on the
RNA-binding activity of IRP1. TCDD effect on IRP1 activity resulted
to be dose-independent.
Interestingly, the decrease in IRP1 binding activity was concom-
itant with an increase in IRP2 RNA-binding activity, essentially
detectable after 48 h of TCDD incubation, reaching the maximum
extent (~155% vs. control) almost at all used concentration. Protracted
treatment up to 72 h did not modify further the RNA-binding activity
of IRP2.
To determine the total amount of IRP1 RNA-binding activity, 2-
mercaptoethanol (2-ME) was added to the binding reaction before the
addition of 32P-labelled IRE to reveal “latent” IRP1 RNA-binding activity,
thus giving the total amount of IRP1 activity (100% of IRE-binding). The
results suggested that TCDD interferes with IRP1 RNA-binding activity
without affecting its cellular content. Moreover, the 2-ME in vitroifferent concentrations of TCDD (0.01, 1, 100 pg/ml), as indicated by numbers (2, 3, 4,
(EMSA). RNA band-shift assay was performed with 5 μg of cytoplasmic proteins and an
in complexes were separated on non-denaturing 6% polyacrylamide gel and revealed by
1-RNA and IRP2-RNA complexes were quantiﬁed by densitometric and results of EMSA
re the average±SEM values of four independent experiments (solid line IRP-1; dotted
.001 compared with controls.
Fig. 2. (A) Western blot analysis showing the IRP1 and IRP2 protein content in MDBK cells incubated with different TCDD concentrations (0.01, 1, 100 pg/ml), as indicated by
numbers (2, 3, and 4, respectively). Shown are blots representative of four independent experiments. Equal amounts of proteins (100 μg) were separated on 8% SDS-polyacrylamide
gel and subjected to Western blot analysis using 1:250 dilution of IRP1 and IRP2 antisera. The anti-β-actin antibody was used to standardize the amounts of proteins in each lane.
(B) After chemiluminescence, the corresponding bands were quantiﬁed by densitometric analysis and plotted in graphs as percentage of control in relation to the used TCDD
concentrations, as indicated. Shown are the average±SEM values of four independent experiments (solid line IRP-1; dotted line IRP-2).
Fig. 3. Response of iron regulatory proteins activity to iron levels in epithelial-like
bovine kidney cells, incubated or not with 1 pg/ml of TCDD for 48 h. For iron repletion–
depletion experiments, MDBK cells were treated with 50 μg/ml ferric ammonium
citrate (FAC) or with 100 μM desferrioxamine (DFO) for 18 h in absence (lanes 3 and 4)
or presence (lanes 5 and 6) of 1 pg/ml TCDD. Proteins were then extracted and
subjected to electrophoretic mobility-shift assay (EMSA). RNA band-shift assay was
performed with 5 μg of cytoplasmic proteins and an excess of 32P-labeled IRE probe in
absence (top) or presence (bottom) of 2% 2-ME. RNA–protein complexes were
separated on non-denaturing 6% polyacrylamide gel and revealed by autoradiography.
The autoradiograms shown are representative of four experiments.
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activity. This is awell knownandunpredictable phenomenondue to the
sensitivity of IRP2 to redox status [21,48]. The modulation of IRP1 and
IRP2 binding activities was not related to protein content, as resulted by
the immunoblot analysis. As shown in Fig. 2, no appreciable variations in
the amounts of IRP1 and IRP2 proteins were observed, suggesting that
the dioxin did not affect the IRP1 and IRP2 expression.
To assess the range of IRP1 and IRP2 regulation in MDBK cells we
treated the cells with iron and iron chelator, and the results are
depicted in Fig. 3. As expected, exposure of cells to ferric ammonium
citrate (FAC) resulted in a reduction of RNA-binding activity of both
IRP1 and IRP2. Conversely, the treatment with desferrioxamine (DFO)
determined an increase of RNA binding of IRP1 and the stabilization of
IRP2. To monitor the response of MDBK cells to dioxin and to
intracellular iron changes we exposed the cells to TCDD (1 pg/ml) for
48 h and then to FAC or DFO for the last 18 h. As shown in Fig. 3, in
TCDD-treated cells the effect of iron addition or chelation is slightly
quenched by the effect of TCDD.
3.3. TCDD inﬂuences TfR-1, ferritin and DMT-1 expression
To evaluate the effects of TCDDexposure onTfR-1,DMT-1 and ferritin
expression in MDBK cells, we determined the levels of these proteins
by Western blot analysis on lysates obtained from cells incubated for
different times in presence of TCDD (0.01, 1 and 100 pg/ml). TCDD
exposure remarkably and progressively increased TfR-1 expression at
the cell membrane. In fact, as shown in Fig. 4, after 72 h of TCDD
exposure there is evidence for a consistent, TCDD concentration-
independent, increase of TfR-1 levels of about 180% with respect to
control cells. TfR-1 levels were unchanged in MDBK cells after 1 h of
TCDD incubation (data not shown).
Bovine kidney cell lysates showed an electrophoretic pattern in
which the H- and L-ferritin subunits overlapped, as previously reported[22]. The ferritin expression showed an original biphasic response with
no TCDD dose–response relationship. In fact, as depicted in Fig. 4,
throughout the early phase of TCDD exposure (with the exception of 1 h
of treatment wherein ferritin level did not change), ferritin protein
content progressively enhanced, reaching an increase of about 1.5-fold
after 24 h. In the late phase of TCDD exposure (48–72 h), ferritin
considerably and rapidly decreased to about 50% of that in control cells.
Furthermore, immunoblot analysis showed that DMT-1 content was
almost unaffected by TCDD exposure.
Fig. 4. (A)Western blot analysis showing the transferrin receptor-1 (TfR-1), the divalent metal transporter-1 (DMT-1), and the ferritin (H/L-Fer) levels in MDBK cells incubated with
different TCDD concentrations (0.01, 1, 100 pg/ml), as indicated by numbers (2, 3, and 4, respectively). Shown are blots representative of four independent experiments. For TfR-1
content analysis, equal amounts of cytosolic lysates containing 100 μg of proteins were fractionated by 8% SDS-PAGE and subjected to Western blot analysis using 1:1000 dilution of
TfR-1 antiserum. For ferritin content analysis, equal amounts of cytosolic lysates containing 100 μg of proteins were fractionated by 12% SDS-PAGE and subjected to Western blot
analysis using 1:1000 dilution of ferritin antiserum. For DMT-1 level analysis, equal amounts of cytosolic lysates containing 100 μg of proteins were fractionated by 8% SDS-PAGE and
subjected to Western blot analysis using 1:250 dilution of DMT-1 antiserum. The anti-β-actin antibody was used to standardize the amounts of proteins in each lane. (B) TfR-1, H/L-
Fer and DMT-1 bands detected by chemiluminescence were quantiﬁed by densitometric analysis and plotted in graphs as percentage of control (solid line TfR-1; broken line ferritin;
dotted line DMT-1) in relation to the used TCDD concentrations, as indicated. Shown are the average±SEM values of four independent experiments. ***pb0.001 vs. control cells.
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expression could result from a transcriptional control, we decided to
analyze at 24 and 48 h the levels of TfR and ferritin mRNAs by means
of RT-PCR and Northern blot analysis, respectively. Fig. 5 (panel A)
shows that treatment of cells with TCDD for 24 and 48 h elicited a
marked increase at all tested concentrations of TfR mRNA levels as
compared to untreated cells. On the other hand exposure of cells to
TCDD led to an increase in ferritin mRNA levels only in the early phase
(24 h) while ferritin mRNA content remained unchanged after 48 h of
TCDD exposure (see Fig. 5, panel B).
3.4. TCDD affects cellular labile iron pool (LIP)
Following TCDD exposure, the modulation of the activity and
expression of the most important proteins involved in the mainte-
nance of cellular iron homeostasis could ultimately lead to a
modiﬁcation of LIP extent. Therefore, to verify this hypothesis we
used calcein (CA) ﬂuorimetric assay to measure the cytosolic pool of
chelatable iron in MBDK cells. This assay is based on the principle that
the CA loaded into cell binds a large fraction of the free iron that is
revealed by the addition of excess of the permeant iron-chelator SIH
that restores CA's ﬂuorescence. The magnitude of the chelator-
mediated rise in ﬂuorescence is proportional to the amount of CA-
bound iron and therefore reﬂects the LIP extent. On the basis of
immunoblot analysis of the proteins devoted to transport (TfR-1) and
segregation (ferritin) of iron (see Fig. 4), we decided to evaluate theLIP extent between 12 and 48 h. The results derived from ﬂuorescence
intensity histograms of experiments where MBDK cells, treated for
the indicated times with 0.01, 1 and 100 pg/ml of TCDD, are depicted
in the Fig. 6. The LIP progressively decreased reaching the lowest level
after 24 h, with a diminution of about 70% respect to control cells.
Then, LIP rapidly increased reaching the maximum after 48 h (about
the 150% respect to untreated cells). The variations in LIP magnitude
were TCDD concentrations-independent.
4. Discussion
Dioxins are known to be a class of highly toxic and persistent
environmental contaminants, among them the 2,3,7,8-tetrachlorodi-
benzo-p-dioxin (TCDD) is believed to be one of the most potent
chemical toxins of current interest. One of the major TCDD in vivo
target organ is the liver, which plays a fundamental function in iron
metabolism [49]. Indeed, TCDD-induced disturbances in iron homeo-
stasis have been reported in correlation with liver injury. Evidence is
consistent with the involvement of iron metabolism genes in dioxin-
induced uroporphyria and liver oxidative injury [41,42].
In the present study, we have provided the ﬁrst evidence in vitro
that exposure of mammalian cells to the toxin TCDD affects the
maintenance of iron homeostasis, causing an opposite modulation of
the iron regulatory proteins activity, with consequent variations in the
expression of the main iron related proteins, and ultimately
signiﬁcant changes in the extent of the intracellular free iron pool.
Fig. 5. TCDD effect on TfR-1 and ferritinmRNA levels in MDBK cells incubated for the indicated times with different TCDD concentrations (0.01, 1, 100 pg/ml), as showed by numbers
(2, 3, and 4, respectively). (A) RT-PCR and its densitometric analysis showing TfR-1 mRNA expression. Shown are RT-PCR analysis representative of three independent experiments.
Total RNAwas reverse-transcribed into cDNAbyusing the randomprimingmethod and then cDNAwas ampliﬁed by PCR using Taq-Polymerase. The TfR-1 andGADPH (house-keeping
gene) cDNAwere co-ampliﬁed as described in Materials and methods section. After gel staining, the bands corresponding to TfR-1 mRNAs were quantiﬁed by densitometric analysis
and plotted in bar graphs as relative units showing the average±SEM values of three independent experiments. ***pb0.001 vs. control cells. (B) Northern blot and its densitometric
analysis showing H-ferritin (H-Fer) mRNA levels. The autoradiograms shown are representative of three independent experiments. Equal amounts (15 μg) of total cellular RNA, as
revealed by ethidium bromide ﬂuorescence of RNA gel, were hybridized to an H-ferritin cDNA 32P-radiolabelled probe. The bands corresponding to H-ferritin mRNAwere quantiﬁed
by densitometric and the mean±SEM of results from three experiments are plotted in bar graphs as relative units. ***pb0.001 vs. control cells.
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that cell exposure to TCDD affects the RNA-binding capacity of both
IRP1 and IRP2. Notably, in our in vitro experimental model TCDD
interfered with iron regulatory proteins activity at a very low dose
(0.01 pg/ml), suggestive of a relevant inﬂuence of dioxin in the
regulation of iron metabolism. We observed a concomitant IRP1
down-regulation and IRP2 up-regulation, more evident at prolonged
exposure times. These effects on IRPs activity showed a time-
dependent and dose-independent proﬁle. This phenomenon is related
to the complexity of mechanisms by which many xenobiotics, such as
halogenated hydrocarbons, polycyclic aromatic hydrocarbons, phtha-
lates and pesticides, exert toxic effects [50]. Indeed, the TCDD effects
on iron metabolism regulation were dose-independent, whereas theincrease inmitochondrial activity and in cell proliferationwere clearly
dependent on the TCDD dose [43].
The treatmentofMDBKcellswith iron anddesferrioxamine, a potent
iron chelator, demonstrates that our experimental model responds to
iron content variation in accordance with the well known iron
regulation of IRPs. Although it appears slightly quenched, the effect of
iron additionor chelation on IRPs activitywaspersistent followingTCDD
exposure. Moreover, the RNA-binding activity assays in the presence of
the reducing agent 2-ME, which converts c-aconitase into the fully
activated IRP1, indicate that the TCDD-dependent decrease in the IRP1
RNA-binding activity is correlated with an increase of c-aconitase form.
Interestingly, no appreciable variations in cellular IRP1 and IRP2
content occurred, thus suggesting that TCDD modulates RNA-binding
Fig. 6. LIP extent following TCDD exposure (0.01,1, 100 pg/ml) in MDBK cells estimated
for the indicated times with the CA ﬂuorescent method. Cell cultures were loaded with
CA using acetomethoxyl-calcein, and ﬂuorescence was measured before and after the
addition of 100 μM permeant iron chelator SIH. Shown are the average±SEM (n=6)
values of three independent experiments plotted in a graph as percent of control
cultures. **pb0.01 vs. control cells; ***pb0.001 vs. control cells.
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accepted model that IRP2 is either functional or degraded, the data
concerning the increased IRP2 activity observed in the RNA-binding
experiments and the results of IRP2 expression seem to be apparently
contradictory, probably because of the low sensitivity of the IRP2
immunoblot experiments.
The observed IRPs regulation by TCDD could be a consequence of a
toxicprocess or a signalingpathway to copewithoxidative stress [41]. The
decrease in IRP1 binding activity is partly consistent with previous results
on livers from TCDD-susceptible mice, showing a depression of IRP1, due
to a down-regulation of protein expression or to an IRE-binding capacity
inactivation [41]. Since the toxic and biochemical effects of TCDD are
mainly if not exclusively dependent on its binding to the cytoplasmic Aryl
hydrocarbonReceptor (AhR), it appears likely that theAhR could also play
a role in the TCDD-dependent regulation of iron metabolism. It is known
that dioxins interfere with the endocrine system acting as Endocrine
Disrupting Chemicals (EDC), hence modifying the regulation of dynamic
cellular processes [30,34]. Bymultiplemechanisms based onAhR-Nuclear
Receptors crosstalk, EDCs exert numerous hormone disruptive activities
[51]. In fact, there is evidence showing a crosstalk between the estrogen
receptors (ERs) and AhR that leads to inhibition of estrogenic signaling.
Theanti-estrogenic inﬂuenceof TCDDonERsignaling iswell documented,
even though the mechanism is not fully characterized [52,53]. Recently,
wehave reported that themolecularmechanismgoverning the regulation
of ferritin and TfR-1 gene expression by estrogen is based on changes in
the IRE binding activity of the IRPs. In particular, we showed a reduced
IRP1binding activity in an in vivomodel of estrogendeﬁciency, suggestive
of a possible hormone-dependent functional regulation of the IRP1 IRE-
binding activity [23]. Accordingly, the reduced IRP1 activity herein
described following the dioxin exposure could be correlated to the
TCDD anti-estrogenic effect.
One intriguing ﬁnding is the concomitant IRP2 up-regulation
following the dioxin exposure. The enhanced activity of IRP2, when
IRP1 activity is low, could be due to compensatorymechanismswithin
iron homeostasis regulation as a consequence of protein over-
expression or/and a misregulation of the intricate E3 ubiquitin ligase
machinery devoted to IRP2 proteasomal degradation. In mammals,
kidney is one of the tissues in which IRP1 is most highly expressed,
contributing signiﬁcantly to regulation of iron metabolism [54].
Nevertheless, in several tissues, as well as kidney, loss of IRP1-binding
activity does not lead to misregulation of iron metabolism, because
IRP2 levels increase in compensation [55]. However, the possibility
cannot be excluded that IRP2 activity may be subjected to as yet
unidentiﬁed regulatory mechanism induced by TCDD.
Modulation of IRPs binding activity would ultimately lead to
changes in iron-related protein expression proﬁling. It is well known
that at post-transcriptional level, the up-regulation of IRPs RNA-
binding activity leads to an increased TfR-1 mRNA translation and to asimultaneous decreased ferritin mRNA translation. In MDBK cells
exposed to TCDD a marked enhancement of TfR-1 expression was
observed, that predictably is associated with enhanced iron uptake,
whereas the cellular DMT-1 levels appear unchanged, suggesting a
minor role of this transporter in the control of iron ﬂux in con-
sequence of the dioxin effect. Concerning ferritin expression, TCDD
exposure determined an original biphasic response with a progressive
increase in ferritin content until 24 h, and then a rapid and substantial
reduction in its content, clearly detectable at 48 and 72 h of exposure.
The increased expression of TfR-1 is dependent by a coupled
transcriptional and post-transcriptional regulation, as also demon-
strated through enhanced TfR-1 mRNA steady-state levels (see Fig. 5,
panel A). As regards the biphasic behaviour of ferritin, the protein
increase after 24 h of treatment is consistent with an increase of
steady-state levels of ferritin mRNA induced by TCDD (see Fig. 5,
panel B), whereas the reduced levels observed after prolonged TCDD
exposure (48–72 h) appear correlated to the increased IRP2 binding
activity without concurrent signiﬁcant variations of mRNA steady-
state levels. Although it is known that in kidney IRP1 mainly
contributes to regulation of iron metabolism, it is feasible that IRP2
can act as the effector of cellular iron homeostasis when the TCDD
exposure is prolonged to 72 h and IRP1 fails in controlling iron sense.
To our knowledge, the present results are the ﬁrst demonstration of a
divergent response of IRP1 and IRP2 to TCDD toxicity.
The simultaneous changes on ferritin content and TfR-1 induction
by TCDD exposure could impair cellular iron homeostasis, ultimately
leading to important alterations of the labile iron pool (LIP) extent.
LIP, the portion of free cellular iron, is mainly localized but not
exclusively in the cytosol and constitutes the catalytic and redox-
active iron. The level of the pool must be maintained within a
restricted range that meets the cell's requirements for iron but
prevents excess from developing cellular oxidative damage [56].
Evaluation of the LIP magnitude in MDBK cells exposed to TCDD
indicated important ﬂuctuations within the pool, largely in relation to
the expression of the iron-withdrawing protein ferritin, the major
controller of the iron pool. In fact, the TCDD-dependent decrease of
cellular ferritin content, coupled with TfR-1 induction detected after
48 h of treatment, was associated with enhanced LIP level. The result
that LIP levels rapidly and markedly changed following TCDD
exposure strongly supports the hypothesis that dioxin causes
alterations in the maintenance of cellular iron homeostasis. Interest-
ingly, although iron repletion would be sufﬁcient to degrade IRP2 via
the E3 ligase ubiquitin proteasomal pathway, IRP2 remains active, a
ﬁnding that reinforces the concept that in our experimental model
this protein is predominant in the control of cellular iron metabolism.
In correlation to the enlarged iron pool at 48 h, we have observed
that cell viability and cell number signiﬁcantly increase in presence of
TCDD in a dose-dependent manner. Hence, since important iron
requirement changes occur during the regulation of cell growth, it is
not surprising that the dioxin-dependent iron metabolism deregula-
tion, herein described, may affect cell-fate decision. Deregulation of
cell proliferation/differentiation processes induced by dioxin coupled
to an iron excess could be ultimately associated to the neoplastic
transformation of the cell and to cancer development [57,58]. This is
supported by a recent report that demonstrates a pro-oncogenic
activity for IRP2 to induce the growth of tumor xenografts [59].
In conclusion, altogether these observations warrant a reconsid-
eration of iron role in TCDD-induced toxicity and highlight a central
connection among the exposure to dioxins, the ﬁne regulation of iron
metabolism and the control of dynamic cellular processes.
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